Evidence map›Paper›PMID 31373897›Full record

ArticleDiagnosis (Berlin, Germany)2019

Follow-up of incidental pulmonary nodules and association with mortality in a safety-net cohort.

Jonathan S Lee, Sarah Lisker, Eric Vittinghoff, Roy Cherian, David B McCoy, Alex Rybkin, George Su, Urmimala Sarkar

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Diagnosis (Berlin, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Observational
  2. Observational
  3. Observational
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jonathan S LeeDivision of General Internal Medicine, University of California, San Francisco, CA 94143-0320, USA.
Sarah LiskerCenter for Vulnerable Populations, University of California, San Francisco, CA 94143-0320, USA.
Eric VittinghoffDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143-0320, USA.
Roy CherianCenter for Vulnerable Populations, University of California, San Francisco, CA 94143-0320, USA.
David B McCoyDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143-0320, USA.
Alex RybkinDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143-0320, USA.
George SuDivision of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco, CA 94143-0320, USA.
Urmimala SarkarCenter for Vulnerable Populations, University of California, San Francisco, CA 94143-0320, USA.
University of California, San Francisco · US

Funding

Improving Survivorship Care for Diverse Cancer Patients Cared for in Safety-net SettingsK24CA212294 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SARKAR, URMIMALA · 2017 to 2021
$831k
AHRQ HHS P30 HS023558NCI NIH HHS K24 CA212294
6 · The paper itself

Abstract

Background Though incidental pulmonary nodules are common, rates of guideline-recommended surveillance and associations between surveillance and mortality are unclear. In this study, we describe adherence (categorized as complete, partial, late and none) to guideline-recommended surveillance among patients with incidental 5-8 mm pulmonary nodules and assess associations between adherence and mortality. Methods This was a retrospective cohort study of 551 patients (≥35 years) with incidental pulmonary nodules conducted from September 1, 2008 to December 31, 2016, in an integrated safety-net health network. Results Of the 551 patients, 156 (28%) had complete, 87 (16%) had partial, 93 (17%) had late and 215 (39%) had no documented surveillance. Patients were followed for a median of 5.2 years [interquartile range (IQR), 3.6-6.7 years] and 82 (15%) died during follow-up. Adjusted all-cause mortality rates ranged from 2.24 [95% confidence interval (CI), 1.24-3.25] deaths per 100 person-years for complete follow-up to 3.30 (95% CI, 2.36-4.23) for no follow-up. In multivariable models, there were no statistically significant associations between the levels of surveillance and mortality (p > 0.16 for each comparison with complete surveillance). Compared with complete surveillance, adjusted mortality rates were non-significantly increased by 0.45 deaths per 100 person-years (95% CI, -1.10 to 2.01) for partial, 0.55 (95% CI, -1.08 to 2.17) for late and 1.05 (95% CI, -0.35 to 2.45) for no surveillance. Conclusions Although guideline-recommended surveillance of small incidental pulmonary nodules was incomplete or absent in most patients, gaps in surveillance were not associated with statistically significant increases in mortality in a safety-net population.

Indexed as

AgedEthnicityFemaleFollow-Up StudiesGuideline AdherenceHumansIncidental FindingsLung NeoplasmsMaleMiddle AgedMortalityMultiple Pulmonary NodulesPatient Care ManagementRetrospective StudiesSafety-net ProvidersTomography, X-Ray Computedadherenceambulatory carecare managementdiagnosisguidelinesunderserved populations

Identifiers

PMID31373897
PMCPMC7757426
OpenAlexW2964822539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.